Pacific Channel   Search
Biomedical Venture Development and Corporate Advisory Register  Login
Home
About Us
Our Team
Our Services
Investment Opportunities
Publications
Articles
Pacific Biotech Bulletin
Our Affiliates
Portfolio Companies
Ingredient Solutions
Contact Us
Events
Ernst & Young
News

Ernst & Young Minimize


Realising Returns from New Zealand Life Sciences Innovation
Jon Hooper, Partner - Ernst & Young

Business and investment models for realizing returns
from New Zealand life sciences innovation
Brent Ogilvie, Executive Director - Pacific Channel Limited

Targeting Orphan Diseases:
ZyStor Therapeutics A Possible Model for New Zealand
Allan R. Goldberg, Ph.D., Managing Partner, The Channel Group

New Models for Creating Investment Value in Biotechnology
Robert Beckman, Managing Partner - The Channel Group

NZ Based Global Operations
Paul Tan, CEO - Living Cell Technologies Limited


 Print   
100 Free Hours. Minimize

Nova Eco Tech Ltd secures 50 free hours of investment advice.

More...

 

Auckland-Brilliant
4 Business
Minimize

More...
 

Grant Guides

Read about Pacific Channel's guide to accessing international grants and contact us for more information. More...

Why invest in
Biotechnology?

The global life sciences industry is one of the greatest sources of innovation available today. More...

Why invest in NZ
Biotechnology
Companies?

New Zealand has a history of excellence in life sciences research in food and agriculture More...

Copyright 2006 Pacific Channel   Terms Of Use  Privacy Statement